Physician profile
Peter Andrews
NPI 1316984255
$14,108.34
in general payments reported to CMS, 2019-2025
27 companies · $1,264 in 2025
The $1,264 reported for 2025 was more than what 77% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,980 · 2020: $299 · 2021: $859 · 2022: $1,171 · 2023: $4,999 · 2024: $1,537 · 2025: $1,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,191 · Consulting Fee: $3,000 · Travel and Lodging: $590 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,190.65 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $590.24 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $4,478.16 | 2019-2025 | |
| Alcon Vision LLC | $2,811.28 | 2019-2025 | Clareon, Wavelight Refractive Suite, Contoura Vision |
| Johnson & Johnson Surgical Vision, INC. | $2,557.29 | 2019-2024 | Tecnis Simplicity, Tecnis Iol |
| Glaukos Corporation | $899.96 | 2020-2025 | Radius, Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Mallinckrodt Hospital Products INC. | $360.30 | 2021-2024 | Acthar |
| Allergan, INC. | $350.73 | 2019-2021 | |
| Harrow Eye, LLC | $296.06 | 2025 | |
| Dompe US, INC. | $285.03 | 2021-2025 | Oxervate |
| New World Medical,INC. | $280.26 | 2022-2024 | Clearpath, Streamline, Kahook Dual Blade |
| Novartis Pharmaceuticals Corporation | $212.04 | 2019-2022 | |
| Rxsight INC | $210.18 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $207.55 | 2019-2021 | |
| Abbvie INC. | $173.39 | 2025 | |
| Sight Sciences, INC. | $167.09 | 2022 | |
| Aerie Pharmaceuticals, INC. | $151.36 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $148.56 | 2022-2025 | Cequa |
| Astellas Pharma US INC | $125.33 | 2025 | Izervay |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Staar Surgical Company | $64.68 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $61.80 | 2021 | |
| Rayner Intraocular Lenses Limited | $42.80 | 2023-2024 | Rayone Emv, Omidria, Rayone Aspheric |
| Bausch & Lomb Americas INC. | $41.34 | 2023-2024 | Xiidra, Miebo |
| Oyster Point Pharma, INC. | $27.27 | 2022 | |
| Amgen INC. | $26.68 | 2024 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $24.34 | 2025 | Xdemvy |
| Thea Pharma INC. | $22.35 | 2023 | Iyuzeh |
| Iridex Corporation | $17.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.